Clinical Trial Update: A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic comparison of two recombinant Exendin-4 formulations conducted in healthy Chinese male subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exendin-4 (recombinant formulation) (exendin-4)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED